Chromosomes in a patient with the Sezary syndrome.
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D002875:Chromosomes / Q000187:drug effects / Q000528:radiation effects; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D003873:Dermatitis, Exfoliative / Q000097:blood / Q000188:drug therapy / Q000235:genetics* / Q000532:radiotherapy; D004171:Diploidy; D005260:Female; D006801:Humans; D007621:Karyotyping; D007645:Keratoderma, Palmoplantar / Q000097:blood / Q000188:drug therapy / Q000235:genetics* / Q000532:radiotherapy; D008206:Lymphatic Diseases / Q000097:blood / Q000188:drug therapy / Q000235:genetics* / Q000532:radiotherapy; D008214:Lymphocytes; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D013577:Syndrome
D000970:Antineoplastic Agents; D003037:Cobalt Radioisotopes; D011241:Prednisone